Clinical Trials in Austin

Showing 11001-11020 of 15,205 trials

MSC2364447C Phase 1b in Systemic Lupus Erythematosus

NCT02537028

The primary purpose of this Phase 1b double-blind, randomized, placebo-controlled trial is to evaluate the safety, tolerability, pharmacokinetic (PK), and biological effect of MSC2364447C administered for 4 weeks in systemic lupus erythematosus subjects (SLE).

Lupus Erythematosus, Systemic

EMD Serono Research & Development Institute, Inc.24 participantsStarted Nov 2015

Anniston, Alabama, United States • El Cajon, California, United States • Lakewood, California, United States +10 more locations

COMPLETEDPhase 2< 1 mile

A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

NCT01730027

This randomised, double-blind, placebo-controlled study will evaluate the efficacy and safety of ADC3680 administered once daily as an add-on therapy to inhaled corticosteroids and when co-administered with montelukast in patients with inadequately-controlled asthma. Patients will be randomised to 3 Arms to receive ADC3680, placebo or montelukast.

Asthma

Pulmagen Therapeutics248 participantsStarted Apr 2013

Birmingham, Alabama, United States • Huntington Beach, California, United States • Riverside, California, United States +84 more locations

MSC2364447C Phase 1b in Systemic Lupus Erythematosus

A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

Find Trials by Condition in Austin

Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001

Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma

A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment

BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer

Time to Eugonadal Range, Time to Steady State and Drying Time

Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers

Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Study of AA4500 in the Treatment of Peyronie's Disease

N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture

AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder

Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component

A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD

Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol